Rheumatoid arthritis: Pathogenic mechanisms and therapeutic targets
Numerous novel therapies are in development for rheumatoid arthritis as a consequence of tremendous progress in understanding pathogenic mechanisms and defining relevant disease cells and molecules. Anti-tumour necrosis factor alpha (TNFα) therapies have been particularly successful and set a new st...
Prif Awduron: | Taylor, P, Feldmann, M |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
2004
|
Eitemau Tebyg
-
Molecular therapeutic targets in rheumatoid arthritis.
gan: Sacre, S, et al.
Cyhoeddwyd: (2005) -
TNF alpha as a therapeutic target in rheumatoid arthritis.
gan: Feldmann, M, et al.
Cyhoeddwyd: (1994) -
TNF alpha is an effective therapeutic target for rheumatoid arthritis.
gan: Feldmann, M, et al.
Cyhoeddwyd: (1995) -
The cytokine network in rheumatoid arthritis: definition of TNF alpha as a therapeutic target.
gan: Feldmann, M
Cyhoeddwyd: (1996) -
TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases
gan: Feldmann, M, et al.
Cyhoeddwyd: (2003)